Can we achieve ESC 2019 guidelines LDL-cholesterol target in Tunisia?

Ibn Elhadj, Zied; Cherif, Nour; Bennour, Emna; Antit, Saoussen; Echaieb, Widad; Zakhama, Lilia; Kachboura, Salem

Ibn Elhadj, Zied; Cherif, Nour; Bennour, Emna; Antit, Saoussen; Echaieb, Widad; Zakhama, Lilia; Kachboura, Salem.

Tunis Med ; 100(2): 156-160, 2022.

Article in En | MEDLINE | ID: mdl-35852251

Subject(s)

Acute Coronary Syndrome; Dyslipidemias; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Acute Coronary Syndrome/epidemiology; Acute Coronary Syndrome/therapy; Cholesterol, LDL; Dyslipidemias/drug therapy; Dyslipidemias/epidemiology; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors/therapeutic use; Middle Aged; Prospective Studies; Risk Factors; Treatment Outcome; Tunisia/epidemiology

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hydroxymethylglutaryl-CoA Reductase Inhibitors / Dyslipidemias / Acute Coronary Syndrome Type of study: Clinical_trials / Etiology_studies / Guideline / Observational_studies / Risk_factors_studies Limits: Humans / Middle aged Country/Region as subject: Africa Language: En Journal: Tunis Med Year: 2022 Document type: Article Country of publication: Tunisia

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google